Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
- Status
- COMPLETED
- Phase
- PHASE2
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
- Status
- COMPLETED
- Phase
- PHASE3
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
- Status
- COMPLETED
- Phase
- N/A
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.
- Status
- UNKNOWN
- Phase
- NA
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
CART-EGFRvIII + Pembrolizumab in GBM
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain
- Status
- TERMINATED
- Phase
- NA
DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1